Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $16.63M | $28.93M | -42.54% |
Operating Income | $-120.81M | $-114M | -5.97% |
Net Income | $-114.33M | $-107.44M | -6.42% |
EPS (Basic) | $-1.10 | $-1.12 | +1.79% |
EPS (Diluted) | $-1.10 | $-1.12 | +1.79% |
R&D Expense | $108.43M | $111.85M | -3.06% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $986.16M | $1.26B | -21.71% |
Current Assets | $551.39M | $884.04M | -37.63% |
Total Liabilities | $206.24M | $223.45M | -7.70% |
Current Liabilities | $112.59M | $97.91M | +14.99% |
Stockholders' Equity | $779.92M | $1.04B | -24.73% |
Cash & Equivalents | $126.88M | $171.98M | -26.22% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-148.93M | $-120.66M | -23.43% |
Investing Cash Flow | $94.33M | $5.9M | +1498.51% |
Financing Cash Flow | $0 | $59.99M | -100.00% |
D&A | $2.5M | $2.51M | -0.56% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -726.6% | -394.0% | -332.57% |
Net Margin | -687.6% | — | — |
ROE | -14.7% | — | — |
ROA | -11.6% | — | — |
Current Ratio | $4.897 | — | — |
Debt to Equity | $0.264 | — | — |
Other companies in Biotechnology